Director's Interest in Shares
17 Janeiro 2008 - 12:44PM
UK Regulatory
RNS Number:0163M
Arana Therapeutics Limited
17 January 2008
For Immediate Release 17 January 2008
ARANA THERAPEUTICS LTD
Grant of Shares to Director Under Performance Share Plan
Arana Therapeutics Ltd, (LSE: AAHx ASX:AAH) ("Arana" or the "Company"), the
Australian biopharmaceutical company, formed through the merger of Peptech and
EvoGenix in August 2007. The Company uses superior technology to develop next
generation drugs that will improve the lives of patients with inflammatory
diseases and cancer. The Company announced today that Dr Phil Jennings, a
director of the Company, has been granted 31,694 ordinary shares of no par value
in the capital of the Company at a price of nil per share under the Performance
Share Plan as approved by Shareholders at the Annual General Meeting held in
February 2005.
+----------+---------+---------+---------+-------------+-----------------+
|Director |Direct or|No. of |Date |Consideration|Subsequent |
| |Indirect |Shares |Granted |(A$) |beneficial |
| |Interest |Granted | | |holding |
+----------+---------+---------+---------+-------------+-----------------+
|Phil |Direct |31,694 |15 |Nil |6,135 (indirect |
|Jennings | | |January | |interest) |
| | | |2008 | | |
| | | | | | |
| | | | | |67,317 (direct |
| | | | | |interest) |
| | | | | | |
| | | | | | |
+----------+---------+---------+---------+-------------+-----------------+
| | | | | | |
+----------+---------+---------+---------+-------------+-----------------+
As a consequence of this grant, the total number of shares of Arana held by Dr
Jennings represents less than 0.1% of the issued share capital.
For further information, please contact:
Arana Therapeutics Ltd
Dr John Chiplin, Chief Executive Officer +61 (0)2 8061 9900
Niall Henderson, Chief Financial Officer +61 (0)2 8061 9900
Buchanan Communications
Lisa Baderoon (lisab@buchanan.uk.com) +44 (0)20 7466 5000
Rebecca Skye Dietrich / Catherine Breen
Nomura Code Securities
Charles Walker +44 (0)20 7776 1206
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSDGGMMDNZGRZM
Arana Therap. (LSE:AAHX)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Arana Therap. (LSE:AAHX)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre Arana Therap. da Bolsa de Valores de Londres bolsa de valores: 0 artigos recentes
Mais Notícias de Arana Therapeutics